|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Culig Z and Bartsch G: Androgen axis in
prostate cancer. J Cell Biochem. 99:373–381. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McConnell JD: Physiologic basis of
endocrine therapy for prostatic cancer. Urol Clin North Am.
18:1–13. 1991.PubMed/NCBI
|
|
4
|
Lu J, Van der Steen T and Tindall DJ: Are
androgen receptor variants a substitute for the full-length
receptor? Nat Rev Urol. 12:137–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding Q, Motoyama J, Gasca S, Mo R, Sasaki
H, Rossant J and Hui CC: Diminished Sonic hedgehog signaling and
lack of floor plate differentiation in Gli2 mutant mice.
Development. 125:2533–2543. 1998.PubMed/NCBI
|
|
6
|
Motoyama J, Liu J, Mo R, Ding Q, Post M
and Hui CC: Essential function of Gli2 and Gli3 in the formation of
lung, trachea and oesophagus. Nat Genet. 20:54–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marigo V, Roberts DJ, Lee SM, Tsukurov O,
Levi T, Gastier JM, Epstein DJ, Gilbert DJ, Copeland NG, Seidman
CE, et al: Cloning, expression, and chromosomal location of SHH and
IHH: Two human homologues of the Drosophila segment polarity gene
hedgehog. Genomics. 28:44–51. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bitgood MJ, Shen L and McMahon AP: Sertoli
cell signaling by Desert hedgehog regulates the male germline. Curr
Biol. 6:298–304. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wen X, Lai CK, Evangelista M, Hongo J-A,
de Sauvage FJ and Scales SJ: Kinetics of hedgehog-dependent
full-length Gli3 accumulation in primary cilia and subsequent
degradation. Mol Cell Biol. 30:1910–1922. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruiz i Altaba A, Palma V and Dahmane N:
Hedgehog-Gli signalling and the growth of the brain. Nat Rev
Neurosci. 3:24–33. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hutchin ME, Kariapper MST, Grachtchouk M,
Wang A, Wei L, Cummings D, Liu J, Michael LE, Glick A and Dlugosz
AA: Sustained Hedgehog signaling is required for basal cell
carcinoma proliferation and survival: Conditional skin
tumorigenesis recapitulates the hair growth cycle. Genes Dev.
19:214–223. 2005. View Article : Google Scholar :
|
|
13
|
Sheng H, Goich S, Wang A, Grachtchouk M,
Lowe L, Mo R, Lin K, de Sauvage FJ, Sasaki H, Hui CC, et al:
Dissecting the oncogenic potential of Gli2: Deletion of an
NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res.
62:5308–5316. 2002.PubMed/NCBI
|
|
14
|
Tojo M, Kiyosawa H, Iwatsuki K, Nakamura K
and Kaneko F: Expression of the GLI2 oncogene and its isoforms in
human basal cell carcinoma. Br J Dermatol. 148:892–897. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Regl G, Kasper M, Schnidar H, Eichberger
T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C,
Frischauf AM and Aberger F: Activation of the BCL2 promoter in
response to Hedgehog/GLI signal transduction is predominantly
mediated by GLI2. Cancer Res. 64:7724–7731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Regl G, Neill GW, Eichberger T, Kasper M,
Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM and Aberger
F: Human GLI2 and GLI1 are part of a positive feedback mechanism in
Basal Cell Carcinoma. Oncogene. 21:5529–5539. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang-Claude J, Dunning A, Schnitzbauer U,
Galmbacher P, Tee L, Wjst M, Chalmers J, Zemzoum I, Harbeck N,
Pharoah PD, et al: The patched polymorphism Pro1315Leu (C3944T) may
modulate the association between use of oral contraceptives and
breast cancer risk. Int J Cancer. 103:779–783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Watkins DN, Berman DM, Burkholder SG, Wang
B, Beachy PA and Baylin SB: Hedgehog signalling within airway
epithelial progenitors and in small-cell lung cancer. Nature.
422:313–317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alam MM, Sohoni S, Kalainayakan SP,
Garrossian M and Zhang L: Cyclopamine tartrate, an inhibitor of
Hedgehog signaling, strongly interferes with mitochondrial function
and suppresses aerobic respiration in lung cancer cells. BMC
Cancer. 16:1502016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stecca B and Ruiz i Altaba A: Brain as a
paradigm of organ growth: Hedgehog-Gli signaling in neural stem
cells and brain tumors. J Neurobiol. 64:476–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thayer SP, di Magliano MP, Heiser PW,
Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del
Castillo C, Yajnik V, et al: Hedgehog is an early and late mediator
of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyazaki Y, Matsubara S, Ding Q, Tsukasa
K, Yoshimitsu M, Kosai K and Takao S: Efficient elimination of
pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in
combination with mTOR inhibition. Mol Cancer. 15:492016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dugum M, Hanouneh I, McIntyre T, Pai R,
Aucejo F, Eghtesad B and Zein N: Sonic hedgehog signaling in
hepato-cellular carcinoma: A pilot study. Mol Clin Oncol.
4:369–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Syu L-J, Zhao X, Zhang Y, Grachtchouk M,
Demitrack E, Ermilov A, Wilbert DM, Zheng X, Kaatz A, Greenson JK,
et al: Invasive mouse gastric adenocarcinomas arising from Lgr5+
stem cells are dependent on crosstalk between the Hedgehog/GLI2 and
mTOR pathways. Oncotarget. 7:10255–10270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karhadkar SS, Bova GS, Abdallah N, Dhara
S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Narita S, So A, Ettinger S, Hayashi N,
Muramaki M, Fazli L, Kim Y and Gleave ME: GLI2 knockdown using an
antisense oligonucleotide induces apoptosis and chemosensitizes
cells to paclitaxel in androgen-independent prostate cancer. Clin
Cancer Res. 14:5769–5777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen M, Feuerstein MA, Levina E, Baghel
PS, Carkner RD, Tanner MJ, Shtutman M, Vacherot F, Terry S, de la
Taille A, et al: Hedgehog/Gli supports androgen signaling in
androgen deprived and androgen independent prostate cancer cells.
Mol Cancer. 9:892010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanchez P, Hernández AM, Stecca B, Kahler
AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S and Ruiz i
Altaba A: Inhibition of prostate cancer proliferation by
interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci
USA. 101:12561–12566. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sheng T, Li C, Zhang X, Chi S, He N, Chen
K, McCormick F, Gatalica Z and Xie J: Activation of the hedgehog
pathway in advanced prostate cancer. Mol Cancer. 3:292004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Azoulay S, Terry S, Chimingqi M, Sirab N,
Faucon H, Gil Diez, de Medina S, Moutereau S, Maillé P, Soyeux P,
Abbou C, et al: Comparative expression of Hedgehog ligands at
different stages of prostate carcinoma progression. J Pathol.
216:460–470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCarthy FRK and Brown AJ: Autonomous
Hedgehog signalling is undetectable in PC-3 prostate cancer cells.
Biochem Biophys Res Commun. 373:109–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Lipinski R, Shaw A, Gipp J and
Bushman W: Lack of demonstrable autocrine hedgehog signaling in
human prostate cancer cell lines. J Urol. 177:1179–1185. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen M, Tanner M, Levine AC, Levina E,
Ohouo P and Buttyan R: Androgenic regulation of hedgehog signaling
pathway components in prostate cancer cells. Cell Cycle. 8:149–157.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gowda PS, Deng JD, Mishra S, Bandyopadhyay
A, Liang S, Lin S, Mahalingam D and Sun LZ: Inhibition of hedgehog
and androgen receptor signaling pathways produced synergistic
suppression of castration-resistant prostate cancer progression.
Mol Cancer Res. 11:1448–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lauth M and Toftgård R: Non-canonical
activation of GLI transcription factors: Implications for targeted
anti-cancer therapy. Cell Cycle. 6:2458–2463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wiederschain D, Wee S, Chen L, Loo A, Yang
G, Huang A, Chen Y, Caponigro G, Yao YM, Lengauer C, et al:
Single-vector inducible lentiviral RNAi system for oncology target
validation. Cell Cycle. 8:498–504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Roessler E, Ermilov AN, Grange DK, Wang A,
Grachtchouk M, Dlugosz AA and Muenke M: A previously unidentified
amino-terminal domain regulates transcriptional activity of
wild-type and disease-associated human GLI2. Hum Mol Genet.
14:2181–2188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu H, Xia L, Shen Q, Zhao M, Gu X,
Bouamar H, Wang B, Sun LZ and Zhu X: Differential effects of GLI2
and GLI3 in regulating cervical cancer malignancy in vitro and in
vivo. Lab Invest. 98:1384–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anders S, Pyl PT and Huber W: HTSeq - a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar
|
|
41
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
45
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
46
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
47
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
48
|
Holzbeierlein J, Lal P, LaTulippe E, Smith
A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, et
al: Gene expression analysis of human prostate carcinoma during
hormonal therapy identifies androgen-responsive genes and
mechanisms of therapy resistance. Am J Pathol. 164:217–227. 2004.
View Article : Google Scholar
|
|
49
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jin RJ, Wang Y, Masumori N, Ishii K,
Tsukamoto T, Shappell SB, Hayward SW, Kasper S and Matusik RJ:
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in
castrated mice. Cancer Res. 64:5489–5495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Antonarakis ES, Lu C, Wang H, Luber B,
Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, et
al: AR-V7 and resistance to enzalutamide and abiraterone in
prostate cancer. N Engl J Med. 371:1028–1038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lu C and Luo J: Decoding the androgen
receptor splice variants. Transl Androl Urol. 2:178–186. 2013.
|
|
53
|
Gregory CW, He B, Johnson RT, Ford OH,
Mohler JL, French FS and Wilson EM: A mechanism for androgen
receptor-mediated prostate cancer recurrence after androgen
deprivation therapy. Cancer Res. 61:4315–4319. 2001.PubMed/NCBI
|
|
54
|
Li N, Chen M, Truong S, Yan C and Buttyan
R: Determinants of Gli2 co-activation of wildtype and naturally
truncated androgen receptors. Prostate. 74:1400–1410. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hu R, Dunn TA, Wei S, Isharwal S, Veltri
RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB, et al:
Ligand-independent androgen receptor variants derived from splicing
of cryptic exons signify hormone-refractory prostate cancer. Cancer
Res. 69:16–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu LL, Xie N, Sun S, Plymate S, Mostaghel
E and Dong X: Mechanisms of the androgen receptor splicing in
prostate cancer cells. Oncogene. 33:3140–3150. 2014. View Article : Google Scholar
|
